Several studies showed that TGF-β treatment induces EMT (Miyazono, 2009; Lin et al., 2020; Kim et al., 2021) and treatment with exosomes derived from these cells increases proliferation and metastasis in HCC cells (Lin et al., 2020) through intercellular communication. Here, TGFB1 is linked to hepatocellular carcinoma.